Thiamphenicol glycinate
ID: ALA1697822
PubChem CID: 53324864
Max Phase: Preclinical
Molecular Formula: C14H18Cl2N2O6S
Molecular Weight: 413.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
ID: ALA1697822
PubChem CID: 53324864
Max Phase: Preclinical
Molecular Formula: C14H18Cl2N2O6S
Molecular Weight: 413.28
Molecule Type: Small molecule
Associated Items:
Synonyms: Thiamphenicol Glycinate | CHEMBL1697822
Canonical SMILES: CS(=O)(=O)c1ccc([C@H](O)[C@@H](COC(=O)CN)NC(=O)C(Cl)Cl)cc1
Standard InChI: InChI=1S/C14H18Cl2N2O6S/c1-25(22,23)9-4-2-8(3-5-9)12(20)10(7-24-11(19)6-17)18-14(21)13(15)16/h2-5,10,12-13,20H,6-7,17H2,1H3,(H,18,21)/t10-,12+/m1/s1
Standard InChI Key: AMGKHLVPQHMHGQ-PWSUYJOCSA-N
Molfile:
RDKit 2D 25 25 0 0 0 0 0 0 0 0999 V2000 -3.3000 0.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0145 -0.1179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0145 -0.9429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3000 -1.3554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5855 -0.9429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5855 -0.1179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7290 -1.3554 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -5.5171 -0.9429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3123 -1.9387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1456 -1.9387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.8710 0.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1566 -0.1178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8710 1.1196 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4421 0.2947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4421 1.1197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.1566 -0.9428 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.4421 -1.3553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4421 -2.1803 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2724 -0.9428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9869 -1.3553 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 0.2724 -0.1178 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 0.2724 1.5322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2724 2.3572 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.9869 1.1197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7013 1.5322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 1 6 2 0 2 3 2 0 3 4 1 0 4 5 2 0 5 6 1 0 3 7 1 0 7 8 1 0 7 9 2 0 7 10 2 0 6 11 1 0 11 12 1 0 11 13 1 6 12 14 1 0 14 15 1 0 12 16 1 1 16 17 1 0 17 18 2 0 17 19 1 0 19 20 1 0 19 21 1 0 15 22 1 0 22 23 2 0 22 24 1 0 24 25 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 413.28 | Molecular Weight (Monoisotopic): 412.0263 | AlogP: -0.09 | #Rotatable Bonds: 8 |
Polar Surface Area: 135.79 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.88 | CX Basic pKa: 7.08 | CX LogP: -0.80 | CX LogD: -0.89 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.40 | Np Likeness Score: -0.09 |
1. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF.. (2008) Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models., 18 (2): [PMID:20020916] [10.1080/15376510701857262] |
Source(1):